JAKi therapy appears to be clinically effective, well tolerated, and safe in patients with refractory IIM, with a particular benefit in ILD. The steroid sparing effect was also a major outcome. Future prospective and controlled studies are warranted to confirm these preliminary results and better define the therapeutic potential of JAKi in IIM.
Building similarity graph...
Analyzing shared references across papers
Loading...
Ana Luís Vasconcelos
António Marinho
Ana Campar
Clinical and Experimental Rheumatology
Universidade do Porto
Hospital Braga
Building similarity graph...
Analyzing shared references across papers
Loading...
Vasconcelos et al. (Tue,) studied this question.
www.synapsesocial.com/papers/69a75d9dc6e9836116a27cb8 — DOI: https://doi.org/10.55563/clinexprheumatol/0yu9gm